- Home
- ARMP vs BMBL Comparison
ARMP vs BMBL Comparison
Compare ARMP & BMBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARMP | BMBL |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | United States |
| Employees | N/A | 1200 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 383.7M | 425.0M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ARMP | BMBL |
|---|---|---|
| Price | $9.69 | $3.87 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 14 |
| Target Price | ★ $15.00 | $4.42 |
| AVG Volume (30 Days) | 43.0K | ★ 4.8M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.40 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,071,643,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 1.88 |
| 52 Week Low | $0.90 | $2.61 |
| 52 Week High | $13.75 | $8.63 |
Technical Indicators
Market Signals| Indicator | ARMP | BMBL |
|---|---|---|
| Relative Strength Index (RSI) | 47.29 | 67.84 |
| Support Level | $5.14 | $3.31 |
| Resistance Level | $12.23 | $5.96 |
| Average True Range (ATR) | 1.09 | 0.22 |
| MACD | -0.24 | 0.12 |
| Stochastic Oscillator | 2.16 | 73.91 |
Price Performance
Historical ComparisonAbout ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About BMBL Bumble Inc.
Bumble Inc is engaged in offering online dating services. The platform enables people to connect and build healthy and equitable relationships on their own terms. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect. The company Operates in USA and also Internationally such as United Kingdom, Czech Republic, and others with maximum of revenue from Other Countries.